5.303 articles found

Automated radiosynthesis and clinical experience of [<sup>18</sup>F]SMBT-1 PET imaging for <i>in vivo</i> evaluation of reactive astrocyte in Parkinson's disease: a pilot study.

Kiatkittikul P, Lerdsirisuk P, Bhuthathorn L, Choolam A, Jantarato A, Kongsakorn P, Chintawan W, Sringam T, Fonghoi N, Vanprom S, Harada R, Okamura N, Furumoto S, Promteangtrong C.

Front Nucl Med · 2025-12-08

DOI: 10.3389/fnume.2025.1718255PMID: 41437980

Nuclear Medicine Imaging Biomarkers in Parkinson's Disease: Past, Present, and Future Directions.

Martini AL, Sestini S, Guarino DS, Feraco P.

Med Sci (Basel) · 2025-12-07

DOI: 10.3390/medsci13040308PMID: 41440540

CX3CR1: a potential microglia-specific PET imaging target in Alzheimer's and Parkinson's diseases.

Yang H, Wang Y, Xu Y, Wang C.

Front Pharmacol · 2025-12-04

DOI: 10.3389/fphar.2025.1678159PMID: 41424797

Correction: Impact of image preprocessing methods on MRI radiomics feature variability and classification performance in Parkinson's disease motor subtype analysis.

Panahi M, Aghamiri SMR, Hosseini MS.

Sci Rep · 2025-12-04

DOI: 10.1038/s41598-025-31359-6PMID: 41345242

Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review.

Mangra S, Szlufik S, Hu CK, Boutet A, Germann J, Lozano AM.

Mov Disord Clin Pract · 2025-12-04

DOI: 10.1002/mdc3.70462PMID: 41346083

Abnormal subthalamic nucleus functional connectivity and machine learning classification in Parkinson's disease: a multisite functional magnetic resonance imaging study.

Qin B, Tang Y, Qin H, Gao W, Liao S, Yang M.

Front Aging Neurosci · 2025-12-03

DOI: 10.3389/fnagi.2025.1695806PMID: 41415889

Brain atrophy and cholinergic denervation in progressive supranuclear palsy: an MRI and [<sup>18</sup>F]-FEOBV PET study.

Kanel P, Roytman S, Carli G, Vangel R, Barr J, Michalakis F, Spears CC, Scott PJH, Albin RL, Bohnen NI.

Front Neurosci · 2025-12-03

DOI: 10.3389/fnins.2025.1695541PMID: 41425069

Echoes of Childhood Trauma: A Rare Case of Holmes Tremor With Neuroanatomic Imaging and Video Evidence.

Prasad R, Gazallo D, Coni RJ.

Cureus · 2025-12-03

DOI: 10.7759/cureus.98408PMID: 41487754

Updates of nuclear medicine imaging in neurodegenerative disorders.

Huang SY, Lin KJ, Hung GU, Hsiao IT.

J Formos Med Assoc · 2025-12-03

DOI: 10.1016/j.jfma.2025.11.032PMID: 41344987

Molecular glucose imaging reveals functional brain reconfiguration by subthalamic deep brain stimulation in Parkinsonian rats.

Chen J, Li N, Muthuraman M, Liang N, Volkmann J, Higuchi T, Ip CW.

Transl Neurodegener · 2025-12-02

DOI: 10.1186/s40035-025-00523-3PMID: 41327361

Imaging pro‐inflammatory microglia in Parkinson’s disease using [11C]SMW139 PET: a multi‐center study

Rikken R, van de Giessen E, Brumberg J, Aarnio R, Joling M, Morén A, Kerstens V, Moein M, Nag S, Halldin C, Fazio P, Roos D, Berendse H, Kassiou M, Wahlroos S, Haaparanta‐Solin M, Oikonen V, Schuit R, Boellaard R, Windhorst A, Jacobs A, Lammertsma A, Rinne J, Varrone A, Golla S.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01

Multi‐scale imaging of α‐synuclein, dopamingeric neurodegeneration and microstructural changes in α‐synuclein PFF mouse model of Parkinson's disease

Combes B, Rosenau A, Huang S, Karatsoli M, Reisert M, Chen Y, Yoshihara H, Keller A, von Elverfeldt D, Jakab A, Oertel W, Nitsch R, Geibl F, Razansky D, Henrich M, Hock C, Ni R.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01